Overview
No overview information available.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Research Report
Comprehensive Report on the Pharmacology and Therapeutic Application of Nitrates
[Introduction and Chemical Foundation]
Defining the Nitrate Moiety (DB14049): From Inorganic Ion to Pharmacological Prodrug
The chemical entity identified by DrugBank ID DB14049 and CAS Number 14797-55-8 is the nitrate ion, a fundamental small molecule with the molecular formula NO3−.[1] It is a polyatomic anion composed of a central nitrogen atom covalently bonded to three identical oxygen atoms in a trigonal planar arrangement, carrying a formal charge of -1.[2] As the conjugate base of nitric acid (
HNO3), the nitrate ion is the principal species present in aqueous solutions at physiological pH (pH 7.3).[1] It is highly soluble in water, a property stemming from its polar nature and its ability to interact with water molecules.[5] The nitrate ion is the more stable oxidized form of nitrogen in the environment compared to the nitrite ion (
NO2−), to which it can be reduced by biotic processes.[5]
While the query specifically identifies this simple inorganic ion, its primary significance in the context of medicine and pharmacology is not as a standalone therapeutic agent but as the core functional moiety of a critically important class of drugs known as organic nitrates.[7] These therapeutic agents are not inorganic salts but are esters of nitric acid, formed by the reaction of nitric acid with alcohols.[1] In this pharmacological context, organic nitrates function as prodrugs; they are biologically inert compounds that, upon administration, undergo metabolic conversion within the body to yield the active signaling molecule responsible for their therapeutic effects.[9] Therefore, a comprehensive understanding of "Nitrate" as a medication requires a detailed examination of this entire drug class, which has been a cornerstone of cardiovascular therapy for over a century.[7]
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2024/11/13 | Phase 3 | Recruiting | |||
2024/10/08 | Not Applicable | Recruiting | |||
2021/11/17 | Phase 4 | Active, not recruiting | |||
2021/07/06 | Not Applicable | UNKNOWN | |||
2021/06/18 | Not Applicable | UNKNOWN | |||
2018/12/26 | Phase 1 | Withdrawn | Gladwin, Mark, MD | ||
2018/08/23 | Phase 2 | Completed | |||
2017/08/23 | Phase 2 | Terminated | |||
2016/12/02 | Phase 1 | Completed | Gladwin, Mark, MD | ||
2013/11/08 | Not Applicable | Terminated |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
No FDA approvals found for this drug. |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
No NMPA approvals found for this drug. |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
No TGA approvals found for this drug. |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
---|---|---|---|---|---|
No Health Canada approvals found for this drug. |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
---|---|---|---|---|---|
No CIMA AEMPS (Spain) approvals found for this drug. |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Philippines FDA approvals found for this drug. |
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Saudi SFDA approvals found for this drug. |
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Malaysia NPRA approvals found for this drug. |
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
---|---|---|---|---|---|
No UK EMC drug information found for this drug. |
Help Us Improve
Your feedback helps us provide better drug information and insights.